Soligenix (SNGX) Capital Expenditures (2010 - 2025)
Soligenix's (SNGX) quarterly Capital Expenditures came in at $1962.0 in Q4 2025, up 222.7% on a QoQ basis from $608.0 in Q3 2025.
Soligenix (SNGX) Capital Expenditures (2010 - 2025) Analysis & Trends
Soligenix (SNGX) has 12 years of Capital Expenditures data on file, last reported at $1962.0 in Q4 2025.
- Quarterly Capital Expenditures changed N/A year-over-year to $1962.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $2570.0 (changed N/A YoY) and the FY2025 annual result came in at $5883.0, changed N/A from the prior year.
- Capital Expenditures climbed to $1962.0 in Q4 2025, from $608.0 in the prior quarter.
- In the past five years, Capital Expenditures ranged from a high of $9823.0 in Q1 2022 to a low of $608.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 112.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 240.20 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 37.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 25.02 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 34.68 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -73.57 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 6.26 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 251.02 Mn |
| 10 | Soligenix | 6.45 Mn | 6.45 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1,962.00 |
| Dec 31, 2025 | 1,962.00 |
| Sep 30, 2025 | 608.00 |
| Sep 30, 2025 | 608.00 |
| Jun 30, 2022 | 3,250.00 |
| Jun 30, 2022 | 3,250.00 |
| Mar 31, 2022 | 9,823.00 |
| Mar 31, 2022 | 9,823.00 |
| Mar 31, 2020 | 7,147.00 |
| Mar 31, 2020 | 7,147.00 |
| Dec 31, 2018 | 1.00 |
| Dec 31, 2018 | 1.00 |
| Mar 31, 2018 | 1,924.00 |
| Mar 31, 2018 | 1,924.00 |
| Dec 31, 2017 | 24,216.00 |
| Dec 31, 2017 | 24,216.00 |
| Sep 30, 2017 | 1.00 |
| Sep 30, 2017 | 1.00 |
| Mar 31, 2017 | 2,131.00 |
| Mar 31, 2017 | 2,131.00 |